Latest On Idera Pharmaceuticals, Inc (IDRA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-01-17 21:02 EST | News | Idera Pharma slips ahead of reverse stock split | N/A |  |
| 2022-11-15 03:29 EST | News | Idera Pharmaceuticals GAAP EPS of -$0.06, revenue of $0.05M | N/A | |
| 2022-09-28 20:09 EST | News | Idera Pharmaceuticals completes acquisition of Aceragen | N/A | |
| 2022-08-10 01:33 EST | News | Idera Pharmaceuticals GAAP EPS of -$0.10 | N/A | |
| 2022-05-18 08:24 EST | News | Idera halts melanoma trial for cancer candidate after early positive results | N/A | |
| 2022-04-19 23:51 EST | News | Regeneron - Checkmate deal propels other developers with similar drugs | N/A | |
| 2022-04-01 07:39 EST | News | Idera Pharmaceuticals GAAP EPS of -$0.08 | N/A | |
| 2021-12-15 12:41 EST | News | Idera says AbbVie has discontinued enrollment in its study for tilsotolimod combo | N/A | |
| 2021-11-09 10:47 EST | News | Idera Pharmaceuticals reports Q3 results | N/A | |
| 2021-08-10 05:43 EST | News | Idera Pharmaceuticals EPS misses by $0.03 | N/A | |
| 2021-07-21 12:09 EST | News | Idera Pharma rises as insider raises stake | N/A | |
| 2021-07-21 12:03 EST | News | Idera Pharmaceuticals up 22% following insider share purchase | N/A | |
| 2021-04-30 12:53 EST | News | Idera Pharmaceuticals EPS beats by $0.07 | N/A | |
| 2021-03-19 20:27 EST | News | Idera suffers downgrades after trial setback; Kiniksa target upped on FDA win; and more in today’s analyst calls | N/A | |
| 2021-03-19 20:25 EST | News | Idera Pharma to face ‘substantial’ financial risk after trial setback: Wedbush | N/A | |
| 2021-03-18 20:32 EST | News | Idera shares plunge 66% following phase 3 melanoma candidate failure (updated) | N/A | |
| 2021-03-16 21:06 EST | Analyst Rating | The Analyst Target Price has increased from $8.33 to $8.6. | Buy | |
| 2021-03-05 07:59 EST | Analyst Rating | The Analyst Target Price has increased from $7.83 to $8.33. | Buy | |
| 2021-03-04 03:53 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-03 08:01 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-02 07:56 EST | Earnings Estimate | An EPS average of -$0.35 is estimated for the 2022 year. | Buy | |
| 2021-03-02 07:56 EST | Earnings Estimate | An EPS average of -$0.16 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-03-01 18:49 EST | News | Idera Pharmaceuticals EPS misses by $1.88 | N/A | |
| 2021-01-14 05:06 EST | News | Idera outlines capital requirement to move tilsotolimod toward commercialization in advanced melanoma | N/A | |
| 2020-12-15 13:35 EST | News | Idera Pharmaceuticals receives $5M in additional proceeds from private placement | N/A | |
| 2020-11-26 20:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 16:30 EST | News | Idera Pharma names new operations chief | N/A | |
| 2020-11-07 16:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-05 08:04 EST | Analyst Rating | The Analyst Target Price has increased from $7.6 to $7.83. | Buy | |
| 2020-11-04 03:50 EST | News | Idera Pharmaceuticals: Enter Now Before Phase III Melanoma Trial Data Is Released | N/A | |
| 2020-11-03 08:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-31 18:28 EST | News | Idera Pharmaceuticals EPS misses by $0.37 | N/A | |
| 2020-10-30 21:05 EST | Earnings Estimate | An EPS average of -$0.11 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-10-05 16:25 EST | Insider Trade | MICHAEL R DOUGHERTY has directly acquired 5,722 shares and currently holds 34,130 shares. | Buy | |
| 2020-10-05 16:25 EST | Insider Trade | JAMES A GERAGHTY has directly acquired 8,666 shares and currently holds 99,919 shares. | Buy | |
| 2020-10-05 16:25 EST | Insider Trade | Mark Alan Goldberg has directly acquired 6,166 shares and currently holds 34,647 shares. | Buy | |
| 2020-10-05 16:25 EST | Insider Trade | HOWARD H PIEN has directly acquired 5,583 shares and currently holds 45,457 shares. | Buy | |
| 2020-10-05 16:25 EST | Insider Trade | CAROL SCHAFER has directly acquired 6,111 shares and currently holds 44,868 shares. | Buy | |
| 2020-09-26 13:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 09:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-13 20:02 EST | News | Idera Pharmaceuticals (IDRA) Investor Presentation - Slideshow | N/A | |
| 2020-08-07 04:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-05 16:18 EST | News | Idera Pharmaceuticals EPS misses by $0.33 | N/A | |
| 2020-07-31 01:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 17:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-15 19:01 EST | Insider Trade | Invest Corp Pillar has indirectly acquired of 749,993 shares. | Buy | |
| 2020-07-15 16:08 EST | News | Idera Pharma secures $5M capital raise | N/A | |
| 2020-07-09 09:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 21:21 EST | Insider Trade | MICHAEL R DOUGHERTY has directly acquired 7,193 shares and currently holds 28,408 shares. | Buy | |
About Idera Pharmaceuticals, Inc (IDRA):
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, metastatic melanoma, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration and supply agreement with AbbVie Inc. and Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
General
- Name Idera Pharmaceuticals, Inc
- Symbol IDRA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 32
- Last Split Factor1:8
- Last Split Date2018-07-30
- Fiscal Year EndDecember
- IPO Date1996-01-24
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.iderapharma.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 42.09
- Price/Book (Most Recent Quarter) 1.24
- Enterprise Value Revenue 25.28
- Enterprise Value EBITDA 0.09
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.67
- Next Year EPS Estimate -$0.38
- Next Quarter EPS Estimate -$0.11
- Return on Assets -51%
- Return on Equity -2281%
- Earnings Per Share -$1.66
- Revenue Per Share $0
- Gross Profit -16707000
- Quarterly Earnings Growth -100%
View More
Highlights
- Market Capitalization 220.16 million
- EBITDA -47638000
- PE Ratio -0.3
- Analyst Target Price $8.6
- Book Value Per Share $1.30
View More
Share Statistics
- Shares Outstanding 42.26 million
- Shares Float 33.4 million
- % Held by Insiders 2774%
- % Held by Institutions 25.17%
- Shares Short 806620
- Shares Short Prior Month 481550
- Short Ratio 1.33
- Short % of Float 3%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 2.1
- 52 Week High $6.14
- 52 Week Low $1.16
- 50 Day Moving Average 4.98
- 200 Day Moving Average 3.76
View More
Dividends
- Dividend Date 2018-07-30
- ExDividend Date N/A
- Dividend Yield 0%
View More
Idera Pharmaceuticals, Inc (IDRA) Dividend Calendar:
IDRA's last dividend payment was made to shareholders on July 30, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Idera Pharmaceuticals, Inc (IDRA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-01 | $N/A | -$2.11 | -$0.23 | -832.39% |
| 2020-09-30 | 2020-10-29 | $N/A | -$0.59 | -$0.22 | -167.57% |
| 2020-06-30 | 2020-08-04 | $N/A | -$0.72 | -$0.39 | -82.51% |
| 2020-03-31 | 2020-04-30 | $N/A | $0.22 | -$0.37 | 159.28% |
| 2019-12-31 | 2020-03-12 | $N/A | -$1.76 | -$0.34 | -419.63% |
| 2019-09-30 | 2019-11-06 | $N/A | -$0.39 | -$0.46 | 15.84% |
| 2019-06-30 | 2019-08-08 | $1.45 million | -$0.39 | -$0.42 | 7.01% |
| 2019-03-31 | 2019-05-02 | $N/A | -$0.40 | -$0.46 | 12.2% |
| 2018-12-31 | 2019-03-06 | $99000 | -$0.44 | -$0.49 | 10.61% |
| 2018-09-30 | 2018-11-06 | $145000 | -$0.43 | -$0.58 | 25.41% |
| 2018-06-30 | 2018-08-02 | $163000 | -$0.59 | -$0.82 | 28.05% |
| 2018-03-31 | 2018-05-09 | $255000 | -$0.80 | -$0.69 | -15.39% |
| 2017-12-31 | 2018-03-07 | $173000 | -$0.64 | -$0.66 | 2.31% |
| 2017-09-30 | 2017-11-06 | $164000 | -$0.80 | -$0.94 | 14.63% |
| 2017-06-30 | 2017-08-07 | $187000 | -$1.12 | -$0.86 | -30.23% |
| 2017-03-31 | 2017-05-04 | $378000 | -$0.80 | -$0.78 | -2.56% |
| 2016-12-31 | 2017-03-15 | $15.28 million | $0.08 | $0.08 | 0% |
| 2016-09-30 | 2016-10-28 | $323000 | -$0.80 | -$0.92 | 13.32% |
| 2016-06-30 | 2016-08-02 | $301000 | -$0.88 | -$0.91 | 2.94% |
| 2016-03-31 | 2016-05-09 | $294000 | -$0.88 | -$0.88 | 0% |
| 2015-12-31 | 2016-03-10 | $190000 | -$0.80 | -$0.88 | 9.32% |
| 2015-09-30 | 2015-11-06 | $20000 | -$0.10 | -$0.11 | 9.09% |
| 2015-06-30 | 2015-08-06 | $5000 | -$0.11 | -$0.11 | 0% |
| 2015-03-31 | 2015-05-11 | $34000 | -$0.12 | -$0.11 | -9.09% |
| 2014-12-31 | 2015-03-12 | $2000 | -$0.14 | -$0.11 | -27.27% |
| 2014-09-30 | 2014-11-07 | $30000 | -$0.11 | -$0.11 | 0% |
| 2014-06-30 | 2014-08-12 | $38000 | -$0.80 | -$0.68 | -17.65% |
| 2014-03-31 | 2014-05-12 | $3000 | -$0.96 | -$0.60 | -60% |
| 2013-12-31 | 2014-03-13 | $4000 | -$0.80 | -$0.60 | -33.33% |
| 2013-09-30 | 2013-11-14 | $7000 | -$0.88 | -$0.88 | 0% |
| 2013-06-30 | 2013-08-15 | $29000 | -$1.20 | -$0.96 | -25% |
| 2013-03-31 | 2013-05-15 | $7000 | -$1.20 | -$1.36 | 11.76% |
| 2012-12-31 | 2013-03-11 | $11000 | -$1.92 | -$1.52 | -26.32% |
| 2012-09-30 | 2012-11-12 | $3000 | -$1.40 | ||
| 2012-06-30 | 2012-08-09 | $28000 | -$1.17 | ||
| 2012-03-31 | 2012-05-09 | $9000 | -$2.00 | -$2.08 | 3.85% |
| 2011-12-31 | 2012-03-14 | $8000 | -$2.80 | -$1.68 | -66.67% |
| 2011-09-30 | 2011-11-09 | $4000 | -$1.60 | -$1.60 | 0% |
| 2011-06-30 | 2011-08-05 | $33000 | -$1.84 | -$2.00 | 8% |
| 2011-03-31 | 2011-05-05 | $8000 | -$2.00 | -$1.64 | -21.95% |
| 2010-12-31 | 2011-03-10 | $1.06 million | -$1.76 | -$1.92 | 8.33% |
| 2010-09-30 | 2010-11-04 | $5.09 million | -$1.44 | -$0.96 | -50% |
| 2010-06-30 | 2010-08-05 | $4.39 million | -$1.84 | $0.16 | -1250% |
| 2010-03-31 | 2010-05-04 | $5.58 million | -$0.64 | -$0.12 | -433.33% |
| 2009-12-31 | 2010-03-10 | $10.18 million | $1.36 | ||
| 2009-09-30 | 2009-11-05 | $6.54 million | $0.01 | -$0.32 | 102.47% |
| 2009-06-30 | 2009-08-04 | $11.5 million | $1.28 | ||
| 2009-03-31 | 2009-05-06 | $6.3 million | -$0.08 | $0.08 | -200% |
| 2008-12-31 | 2009-03-11 | $6.27 million | $0.08 | $0.05 | 60% |
| 2008-09-30 | 2008-11-06 | $7.52 million | $0.64 | -$0.16 | 500% |
| 2008-06-30 | 2008-08-01 | $7.88 million | $0.40 | -$0.69 | 157.97% |
| 2008-03-31 | 2008-05-12 | $4.78 million | -$0.80 | $0.97 | -182.47% |
| 2007-12-31 | 2008-03-04 | $2.23 million | -$1.68 | -$1.48 | -13.51% |
| 2007-09-30 | 2007-11-13 | $1.97 million | -$1.20 | -$1.77 | 32.2% |
| 2007-06-30 | 2007-08-01 | $1.95 million | -$1.12 | -$1.32 | 15.15% |
| 2007-03-31 | 2007-05-14 | $1.83 million | -$0.96 | -$1.76 | 45.45% |
| 2006-12-31 | 2007-03-06 | $591000 | -$2.08 | -$1.72 | -20.93% |
| 2006-09-30 | 2006-11-14 | $573000 | -$1.76 | -$2.00 | 12% |
| 2006-06-30 | 2006-08-14 | $621000 | -$2.08 | -$1.52 | -36.84% |
| 2006-03-31 | 2006-05-12 | $636000 | -$2.06 | ||
| 2005-09-30 | 2005-11-09 | $545000 | -$1.92 | $1.28 | -250% |
| 2005-06-30 | 2005-08-09 | $312000 | -$1.92 | -$1.92 | 0% |
| 2005-03-31 | 2005-05-10 | $171000 | -$1.86 | ||
| 2004-12-31 | 2005-03-28 | $132000 | -$1.92 | -$2.56 | 25% |
| 2004-09-30 | 2004-11-12 | $78000 | -$2.56 | -$2.56 | 0% |
| 2004-06-30 | 2004-08-06 | $88000 | -$1.92 | -$2.56 | 25% |
| 2004-03-31 | 2004-05-17 | $645000 | -$4.48 | -$3.20 | -40% |
| 2003-12-31 | 2004-03-23 | $109000 | -$6.40 | -$3.20 | -100% |
| 2003-09-30 | 2003-11-14 | $333000 | -$6.08 | ||
| 2003-06-30 | 2003-08-14 | $121000 | -$7.70 | ||
| 2003-03-31 | 2003-05-15 | $334000 | -$8.85 | ||
| 2002-09-30 | 2002-09-30 | $28.18 million | $21.60 | ||
| 2002-06-30 | 2002-06-30 | $699000 | -$3.63 | ||
| 2002-03-31 | 2002-03-31 | $691000 | -$2.55 | ||
| 2001-12-31 | 2001-12-31 | $656000 | -$5.81 | ||
| 2001-09-30 | 2001-09-30 | $154000 | -$7.01 | ||
| 2001-06-30 | 2001-06-30 | $253000 | $3.66 | ||
| 2001-03-31 | 2001-03-31 | $59000 | -$7.60 | ||
| 2000-12-31 | 2000-12-31 | $198000 | -$8.40 | ||
| 2000-09-30 | 2000-09-30 | $44000 | $9.40 | ||
| 2000-06-30 | 2000-06-30 | $25000 | -$12.82 | ||
| 2000-03-31 | 2000-03-31 | $78000 | -$14.86 | ||
| 1999-09-30 | 1999-09-30 | -$15.25 | |||
| 1999-06-30 | 1999-06-30 | -$15.16 | |||
| 1999-03-31 | 1999-03-31 | -$16.76 | |||
| 1998-09-30 | 1998-11-18 | -$40.96 | -$22.40 | -82.86% | |
| 1998-06-30 | 1998-06-30 | $9.32 | |||
| 1998-03-31 | 1998-03-31 | -$109.82 | |||
| 1997-12-31 | 1998-03-19 | -$233.60 | -$105.60 | -121.21% | |
| 1997-09-30 | 1997-10-08 | -$220.80 | -$112.00 | -97.14% | |
| 1997-03-31 | 1997-05-15 | -$179.20 | -$105.60 | -69.7% | |
| 1996-12-31 | 1997-03-12 | -$185.60 | -$118.40 | -56.76% | |
| 1996-09-30 | 1996-11-13 | -$144.00 | -$76.80 | -87.5% |
Idera Pharmaceuticals, Inc (IDRA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | 4.77 million | 5.38 million | N/A | 8.37 million |
| Income Before Tax | N/A | -20.55 million | -24.23 million | N/A | -23.23 million |
| Selling General Administrative | N/A | 2.72 million | 2.63 million | N/A | 3.42 million |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | -7.47 million | -7.99 million | N/A | -11.79 million |
| Operating Income | N/A | -7.48 million | -8.01 million | N/A | -11.79 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | -13.08 million | -16.24 million | N/A | -11.44 million |
| Net Income From Continuing Operations | N/A | -20.55 million | -24.23 million | N/A | -23.23 million |
| Net Income Applicable to Common Shares | -76.7 million | N/A | -24.23 million | 8.82 million | -51.28 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -3.44 million | 2.4 million | N/A | 6.2 million | 3.54 million |
| Change to Liabilities | N/A | -723000 | N/A | 152000 | 1.17 million |
| Total Cash Flow from Investing Activities | N/A | 2.4 million | N/A | 6.2 million | 3.54 million |
| Net Borrowings | N/A | N/A | N/A | -6000 | N/A |
| Total Cash Flow from Financial Activities | 5.06 million | 5.85 million | N/A | 11.54 million | 29000 |
| Change to Operating Activities | N/A | -490000 | N/A | 146000 | -1.88 million |
| Change in Cash | -5.48 million | -99000 | N/A | 7.41 million | -7.27 million |
| Total Cash from Operating Activities | -7.09 million | -8.35 million | N/A | -10.33 million | -10.84 million |
| Depreciation | 11000 | 17000 | N/A | 26000 | 27000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | 6000 | N/A |
| Change to Net Income | N/A | 17.07 million | N/A | 12.58 million | 971000 |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 133.57 million | 64.77 million | N/A | N/A | 58.66 million |
| Total Stockholder Equity | -91.17 million | -32.44 million | N/A | N/A | -11.17 million |
| Other Current Liabilities | 626000 | N/A | N/A | N/A | 46.44 million |
| Total Assets | 42.4 million | 32.34 million | N/A | N/A | 47.49 million |
| Common Stock | 38000 | N/A | 34000 | -144000 | 30000 |
| Other Current Assets | 3.63 million | N/A | N/A | N/A | N/A |
| Retained Earnings | -833.55 million | -756.85 million | -736.3 million | N/A | -720.89 million |
| Other Liabilities | N/A | N/A | 44.13 million | 37.21 million | 3.24 million |
| Other Assets | N/A | N/A | 70000 | 3.58 million | 70000 |
| Cash | 33.23 million | 22.33 million | N/A | N/A | 40.02 million |
| Total Current Liabilities | 7.03 million | 6.81 million | N/A | N/A | 54.52 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 44000 | N/A | 1.03 million | N/A | 1.15 million |
| Total Current Assets | 41.36 million | 31.24 million | N/A | N/A | 46.27 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -91.17 million | N/A | -17.69 million | -144000 | -11.17 million |
| Short Term Investments | 4.5 million | 6.65 million | N/A | N/A | 2.77 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 6.4 million | 310000 | N/A | N/A | 457000 |
Idera Pharmaceuticals, Inc (IDRA) Chart:
Idera Pharmaceuticals, Inc (IDRA) News:
Below you will find a list of latest news for Idera Pharmaceuticals, Inc (IDRA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Idera Pharmaceuticals, Inc (IDRA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest IDRA Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $0.4335 |
| Jun 13, 2022 7:59 PM EST | 300 | $0.4335 |
| Jun 13, 2022 7:59 PM EST | 95 | $0.4335 |
| Jun 13, 2022 7:59 PM EST | 190 | $0.4335 |
| Jun 13, 2022 7:59 PM EST | 95 | $0.4335 |
Idera Pharmaceuticals, Inc (IDRA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008008/0001179110-20-008008-index.htm |
| 2020-06-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/861838/000000000020005108/0000000000-20-005108-index.htm |
| 2020-08-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/861838/000000000020007299/0000000000-20-007299-index.htm |
| 2020-08-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/861838/000000000020007300/0000000000-20-007300-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/861838/000021545719006740/0000215457-19-006740-index.htm |
| 2019-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/861838/000021545719008199/0000215457-19-008199-index.htm |
| 2019-08-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000089924319020986/0000899243-19-020986-index.htm |
| 2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000089924319027012/0000899243-19-027012-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000089924320005917/0000899243-20-005917-index.htm |
| 2020-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000089924320010617/0000899243-20-010617-index.htm |
| 2020-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000089924320019207/0000899243-20-019207-index.htm |
| 2020-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000089924320024396/0000899243-20-024396-index.htm |
| 2020-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000089924320024397/0000899243-20-024397-index.htm |
| 2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/861838/000104746919002568/0001047469-19-002568-index.htm |
| 2020-03-25 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/861838/000104746920001756/0001047469-20-001756-index.htm |
| 2020-04-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/861838/000104746920002090/0001047469-20-002090-index.htm |
| 2018-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465918065598/0001104659-18-065598-index.htm |
| 2018-11-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000110465918065774/0001104659-18-065774-index.htm |
| 2018-11-02 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000110465918065781/0001104659-18-065781-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465918066369/0001104659-18-066369-index.htm |
| 2018-11-26 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/861838/000110465918069927/0001104659-18-069927-index.htm |
| 2018-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465918069928/0001104659-18-069928-index.htm |
| 2018-12-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465918072949/0001104659-18-072949-index.htm |
| 2018-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465918073565/0001104659-18-073565-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919000987/0001104659-19-000987-index.htm |
| 2019-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919001373/0001104659-19-001373-index.htm |
| 2019-03-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/861838/000110465919013132/0001104659-19-013132-index.htm |
| 2019-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919013146/0001104659-19-013146-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919014475/0001104659-19-014475-index.htm |
| 2019-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919020569/0001104659-19-020569-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919026493/0001104659-19-026493-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919034304/0001104659-19-034304-index.htm |
| 2019-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919036588/0001104659-19-036588-index.htm |
| 2019-07-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/861838/000110465919039950/0001104659-19-039950-index.htm |
| 2019-07-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/861838/000110465919039951/0001104659-19-039951-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919044743/0001104659-19-044743-index.htm |
| 2019-08-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919047976/0001104659-19-047976-index.htm |
| 2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919048568/0001104659-19-048568-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000110465919052801/0001104659-19-052801-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000110465919052802/0001104659-19-052802-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000110465919052803/0001104659-19-052803-index.htm |
| 2019-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919058465/0001104659-19-058465-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919060509/0001104659-19-060509-index.htm |
| 2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465919075573/0001104659-19-075573-index.htm |
| 2020-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920003617/0001104659-20-003617-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920004142/0001104659-20-004142-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920007208/0001104659-20-007208-index.htm |
| 2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920029448/0001104659-20-029448-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920032158/0001104659-20-032158-index.htm |
| 2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920044195/0001104659-20-044195-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920049013/0001104659-20-049013-index.htm |
| 2020-05-01 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/861838/000110465920054959/0001104659-20-054959-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920054980/0001104659-20-054980-index.htm |
| 2020-05-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/861838/000110465920060209/0001104659-20-060209-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920061176/0001104659-20-061176-index.htm |
| 2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920062948/0001104659-20-062948-index.htm |
| 2020-06-02 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/861838/000110465920068685/0001104659-20-068685-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920068688/0001104659-20-068688-index.htm |
| 2020-06-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/861838/000110465920071706/0001104659-20-071706-index.htm |
| 2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920073410/0001104659-20-073410-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920083600/0001104659-20-083600-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920090303/0001104659-20-090303-index.htm |
| 2020-08-04 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/861838/000110465920090366/0001104659-20-090366-index.htm |
| 2020-08-04 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/861838/000110465920090374/0001104659-20-090374-index.htm |
| 2020-08-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/861838/000110465920094173/0001104659-20-094173-index.htm |
| 2020-08-31 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/861838/000110465920100609/0001104659-20-100609-index.htm |
| 2020-09-02 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/861838/000110465920101910/0001104659-20-101910-index.htm |
| 2020-09-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/861838/000110465920101913/0001104659-20-101913-index.htm |
| 2020-09-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/861838/000110465920102042/0001104659-20-102042-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920102044/0001104659-20-102044-index.htm |
| 2020-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920109148/0001104659-20-109148-index.htm |
| 2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/861838/000110465920119552/0001104659-20-119552-index.htm |
| 2019-06-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/861838/000114420419030116/0001144204-19-030116-index.htm |
| 2019-09-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/861838/000114420419043821/0001144204-19-043821-index.htm |
| 2018-12-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911018014191/0001179110-18-014191-index.htm |
| 2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911018014192/0001179110-18-014192-index.htm |
| 2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911018014193/0001179110-18-014193-index.htm |
| 2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911018014194/0001179110-18-014194-index.htm |
| 2018-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911018014243/0001179110-18-014243-index.htm |
| 2018-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911018014244/0001179110-18-014244-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019000223/0001179110-19-000223-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019000526/0001179110-19-000526-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019000528/0001179110-19-000528-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019000530/0001179110-19-000530-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019000532/0001179110-19-000532-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019000534/0001179110-19-000534-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019000536/0001179110-19-000536-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019004542/0001179110-19-004542-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019004543/0001179110-19-004543-index.htm |
| 2019-04-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019004896/0001179110-19-004896-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019004897/0001179110-19-004897-index.htm |
| 2019-04-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019004898/0001179110-19-004898-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019004899/0001179110-19-004899-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019007275/0001179110-19-007275-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019007276/0001179110-19-007276-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019007277/0001179110-19-007277-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019007278/0001179110-19-007278-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019007279/0001179110-19-007279-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019007280/0001179110-19-007280-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019007281/0001179110-19-007281-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008387/0001179110-19-008387-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008389/0001179110-19-008389-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008592/0001179110-19-008592-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008594/0001179110-19-008594-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008595/0001179110-19-008595-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008596/0001179110-19-008596-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008597/0001179110-19-008597-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008598/0001179110-19-008598-index.htm |
| 2019-07-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008764/0001179110-19-008764-index.htm |
| 2019-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911019008765/0001179110-19-008765-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000286/0001179110-20-000286-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000287/0001179110-20-000287-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000446/0001179110-20-000446-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000447/0001179110-20-000447-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000448/0001179110-20-000448-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000449/0001179110-20-000449-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000450/0001179110-20-000450-index.htm |
| 2020-01-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000555/0001179110-20-000555-index.htm |
| 2020-01-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000557/0001179110-20-000557-index.htm |
| 2020-01-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000559/0001179110-20-000559-index.htm |
| 2020-01-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000560/0001179110-20-000560-index.htm |
| 2020-01-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000561/0001179110-20-000561-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000562/0001179110-20-000562-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000563/0001179110-20-000563-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000564/0001179110-20-000564-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000565/0001179110-20-000565-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000566/0001179110-20-000566-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020000567/0001179110-20-000567-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020004657/0001179110-20-004657-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020004660/0001179110-20-004660-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020004665/0001179110-20-004665-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020004666/0001179110-20-004666-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020004667/0001179110-20-004667-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020006345/0001179110-20-006345-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020006346/0001179110-20-006346-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020006348/0001179110-20-006348-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020006349/0001179110-20-006349-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020006350/0001179110-20-006350-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020006351/0001179110-20-006351-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020006352/0001179110-20-006352-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008004/0001179110-20-008004-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008005/0001179110-20-008005-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008006/0001179110-20-008006-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008007/0001179110-20-008007-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008008/0001179110-20-008008-index.htm |
| 2020-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008427/0001179110-20-008427-index.htm |
| 2020-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008428/0001179110-20-008428-index.htm |
| 2020-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008429/0001179110-20-008429-index.htm |
| 2020-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008430/0001179110-20-008430-index.htm |
| 2020-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020008431/0001179110-20-008431-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020010219/0001179110-20-010219-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020010220/0001179110-20-010220-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020010221/0001179110-20-010221-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020010222/0001179110-20-010222-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000117911020010223/0001179110-20-010223-index.htm |
| 2019-07-25 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/861838/000119312519202533/0001193125-19-202533-index.htm |
| 2020-02-20 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/861838/000119312520043451/0001193125-20-043451-index.htm |
| 2020-05-07 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/861838/000119312520135295/0001193125-20-135295-index.htm |
| 2020-08-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/861838/000119312520222471/0001193125-20-222471-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/861838/000155837018008638/0001558370-18-008638-index.htm |
| 2019-03-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/861838/000155837019001585/0001558370-19-001585-index.htm |
| 2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/861838/000155837019003862/0001558370-19-003862-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/861838/000155837019007598/0001558370-19-007598-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/861838/000155837019010156/0001558370-19-010156-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/861838/000155837020002458/0001558370-20-002458-index.htm |
| 2020-04-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/861838/000155837020004804/0001558370-20-004804-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/861838/000155837020009151/0001558370-20-009151-index.htm |
| 2020-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/861838/000155837020012053/0001558370-20-012053-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000163859919000063/0001638599-19-000063-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000163859919000404/0001638599-19-000404-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000163859919000597/0001638599-19-000597-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/861838/000163859919000642/0001638599-19-000642-index.htm |
| 2020-06-11 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/861838/999999999520001407/9999999995-20-001407-index.htm |
| 2020-08-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/861838/999999999520002158/9999999995-20-002158-index.htm |
| 2020-09-02 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/861838/999999999520002343/9999999995-20-002343-index.htm |
Idera Pharmaceuticals, Inc (IDRA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Idera Pharmaceuticals, Inc (IDRA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2774%Institutional Ownership: 2517%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-12-19 | Mark Alan Goldberg | Director | Buy | 10,000.00 | 3.19 | 31,897.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911018014193/0001179110-18-014193-index.htm |
| 2019-04-01 | CAROL SCHAFER | Director | Buy | 5,166.00 | 2.59 | 13,379.94 | 10,166.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019004542/0001179110-19-004542-index.htm |
| 2020-01-02 | MICHAEL R DOUGHERTY | Director | Buy | 7,037.00 | 1.85 | 13,018.45 | 11,156.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000287/0001179110-20-000287-index.htm |
| 2019-07-01 | HOWARD H PIEN | Director | Buy | 4,469.00 | 2.61 | 11,664.09 | 11,790.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019008389/0001179110-19-008389-index.htm |
| 2020-01-10 | MILANO VINCENT | President & CEO | Buy | 37,000.00 | 123,560.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000562/0001179110-20-000562-index.htm | ||
| 2019-01-03 | John J. Kirby | VP of Finance | Buy | 10,250.00 | 12,509.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019000530/0001179110-19-000530-index.htm | ||
| 2019-07-01 | CAROL SCHAFER | Director | Buy | 5,179.00 | 2.61 | 13,517.19 | 15,345.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019008387/0001179110-19-008387-index.htm |
| 2020-01-07 | JONATHAN MICHAEL YINGLING | Chief Scientific Officer | Sell | 1,742.00 | 1.78 | 3,101.46 | 16,358.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000450/0001179110-20-000450-index.htm |
| 2019-10-01 | HOWARD H PIEN | Director | Buy | 4,610.00 | 2.67 | 12,308.70 | 16,400.00 | https://www.sec.gov/Archives/edgar/data/861838/000110465919052803/0001104659-19-052803-index.htm |
| 2020-01-07 | John J. Kirby | Chief Financial Officer | Sell | 911.00 | 1.78 | 1,621.94 | 16,437.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000448/0001179110-20-000448-index.htm |
| 2020-01-07 | Robert C. Fletcher | Sr. VP, Bus. Dev. & Strategy | Sell | 1,615.00 | 1.78 | 2,875.35 | 16,485.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000447/0001179110-20-000447-index.htm |
| 2019-01-03 | JONATHAN MICHAEL YINGLING | Chief Scientific Officer | Buy | 18,100.00 | 18,100.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019000536/0001179110-19-000536-index.htm | ||
| 2019-01-03 | Robert C. Fletcher | Sr. VP, Bus. Dev. & Strategy | Buy | 18,100.00 | 18,100.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019000532/0001179110-19-000532-index.htm | ||
| 2020-01-10 | Elizabeth Ann Tarka | Chief Medical Officer | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000566/0001179110-20-000566-index.htm | ||
| 2019-01-03 | Joanna Horobin | Chief Medical Officer | Buy | 18,100.00 | 20,144.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019000534/0001179110-19-000534-index.htm | ||
| 2018-12-20 | Joanna Horobin | Chief Medical Officer | Buy | 300.00 | 3.45 | 1,035.00 | 2,044.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911018014194/0001179110-18-014194-index.htm |
| 2019-10-01 | CAROL SCHAFER | Director | Buy | 5,098.00 | 2.67 | 13,611.66 | 20,443.00 | https://www.sec.gov/Archives/edgar/data/861838/000110465919052801/0001104659-19-052801-index.htm |
| 2020-04-01 | Mark Alan Goldberg | Director | Buy | 10,730.00 | 1.28 | 13,734.40 | 20,730.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020004665/0001179110-20-004665-index.htm |
| 2020-04-01 | MICHAEL R DOUGHERTY | Director | Buy | 10,059.00 | 1.28 | 12,875.52 | 21,215.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020004657/0001179110-20-004657-index.htm |
| 2020-01-07 | Bryant David Lim | SVP and General Counsel | Sell | 1,603.00 | 1.78 | 2,853.98 | 21,240.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000446/0001179110-20-000446-index.htm |
| 2019-01-03 | Bryant David Lim | SVP and General Counsel | Buy | 18,100.00 | 22,843.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019000528/0001179110-19-000528-index.htm | ||
| 2020-01-02 | HOWARD H PIEN | Director | Buy | 6,790.00 | 1.85 | 12,561.50 | 23,190.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000286/0001179110-20-000286-index.htm |
| 2020-07-01 | MICHAEL R DOUGHERTY | Director | Buy | 7,193.00 | 1.79 | 12,875.47 | 28,408.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020008004/0001179110-20-008004-index.htm |
| 2020-07-01 | Mark Alan Goldberg | Director | Buy | 7,751.00 | 1.79 | 13,874.29 | 28,481.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020008006/0001179110-20-008006-index.htm |
| 2019-01-02 | HOWARD H PIEN | Director | Buy | 2,929.00 | 3.52 | 10,310.08 | 2,929.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019000223/0001179110-19-000223-index.htm |
| 2020-04-01 | CAROL SCHAFER | Director | Buy | 10,633.00 | 1.28 | 13,610.24 | 31,076.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020004667/0001179110-20-004667-index.htm |
| 2020-01-29 | Invest Corp Pillar | 10% Share Holder | Sell | 17,250.00 | 1.76 | 30,437.63 | 3,254,442.00 | https://www.sec.gov/Archives/edgar/data/861838/000089924320005917/0000899243-20-005917-index.htm |
| 2020-01-28 | Invest Corp Pillar | 10% Share Holder | Sell | 12,532.00 | 1.76 | 22,081.38 | 3,271,692.00 | https://www.sec.gov/Archives/edgar/data/861838/000089924320005917/0000899243-20-005917-index.htm |
| 2020-01-27 | Invest Corp Pillar | 10% Share Holder | Sell | 15,000.00 | 1.77 | 26,550.00 | 3,284,224.00 | https://www.sec.gov/Archives/edgar/data/861838/000089924320005917/0000899243-20-005917-index.htm |
| 2020-04-01 | HOWARD H PIEN | Director | Buy | 9,666.00 | 1.28 | 12,372.48 | 32,856.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020004666/0001179110-20-004666-index.htm |
| 2019-11-08 | Invest Corp Pillar | 10% Share Holder | Sell | 9,000.00 | 2.44 | 21,960.00 | 3,299,224.00 | https://www.sec.gov/Archives/edgar/data/861838/000089924319027012/0000899243-19-027012-index.htm |
| 2019-11-07 | Invest Corp Pillar | 10% Share Holder | Sell | 10,000.00 | 2.45 | 24,500.00 | 3,308,224.00 | https://www.sec.gov/Archives/edgar/data/861838/000089924319027012/0000899243-19-027012-index.htm |
| 2019-11-06 | Invest Corp Pillar | 10% Share Holder | Sell | 100,000.00 | 2.50 | 249,560.00 | 3,318,224.00 | https://www.sec.gov/Archives/edgar/data/861838/000089924319027012/0000899243-19-027012-index.htm |
| 2020-10-01 | MICHAEL R DOUGHERTY | Director | Buy | 5,722.00 | 2.25 | 12,874.50 | 34,130.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020010219/0001179110-20-010219-index.htm |
| 2020-10-01 | Mark Alan Goldberg | Director | Buy | 6,166.00 | 2.25 | 13,873.50 | 34,647.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020010221/0001179110-20-010221-index.htm |
| 2019-07-01 | BROS. ADVISORS LP BAKER | 10% Share Holder | Buy | 2,964.00 | 2.61 | 7,736.04 | 350,721.00 | https://www.sec.gov/Archives/edgar/data/861838/000163859919000642/0001638599-19-000642-index.htm |
| 2020-01-10 | JONATHAN MICHAEL YINGLING | Chief Scientific Officer | Buy | 20,000.00 | 36,358.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000567/0001179110-20-000567-index.htm | ||
| 2020-01-10 | John J. Kirby | Chief Financial Officer | Buy | 20,000.00 | 36,437.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000563/0001179110-20-000563-index.htm | ||
| 2020-01-10 | Robert C. Fletcher | Sr. VP, Bus. Dev. & Strategy | Buy | 20,000.00 | 36,485.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000564/0001179110-20-000564-index.htm | ||
| 2020-07-01 | CAROL SCHAFER | Director | Buy | 7,681.00 | 1.79 | 13,748.99 | 38,757.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020008008/0001179110-20-008008-index.htm |
| 2020-07-01 | HOWARD H PIEN | Director | Buy | 7,018.00 | 1.79 | 12,562.22 | 39,874.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020008007/0001179110-20-008007-index.htm |
| 2019-10-01 | MICHAEL R DOUGHERTY | Director | Buy | 4,119.00 | 2.67 | 10,997.73 | 4,119.00 | https://www.sec.gov/Archives/edgar/data/861838/000110465919052802/0001104659-19-052802-index.htm |
| 2020-01-10 | Bryant David Lim | SVP and General Counsel | Buy | 20,000.00 | 41,240.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000565/0001179110-20-000565-index.htm | ||
| 2019-01-02 | BROS. ADVISORS LP BAKER | Director | Buy | 3,658.00 | 3.52 | 12,876.16 | 4,283,870.00 | https://www.sec.gov/Archives/edgar/data/861838/000163859919000063/0001638599-19-000063-index.htm |
| 2019-04-01 | BROS. ADVISORS LP BAKER | Director | Buy | 4,161.00 | 2.59 | 10,776.99 | 4,288,031.00 | https://www.sec.gov/Archives/edgar/data/861838/000163859919000404/0001638599-19-000404-index.htm |
| 2019-07-01 | BROS. ADVISORS LP BAKER | 10% Share Holder | Buy | 2,964.00 | 2.61 | 7,736.04 | 4,290,995.00 | https://www.sec.gov/Archives/edgar/data/861838/000163859919000642/0001638599-19-000642-index.htm |
| 2020-10-01 | CAROL SCHAFER | Director | Buy | 6,111.00 | 2.25 | 13,749.75 | 44,868.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020010223/0001179110-20-010223-index.htm |
| 2020-10-01 | HOWARD H PIEN | Director | Buy | 5,583.00 | 2.25 | 12,561.75 | 45,457.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020010222/0001179110-20-010222-index.htm |
| 2018-12-21 | Bryant David Lim | SVP and General Counsel | Buy | 4,000.00 | 3.05 | 12,200.00 | 4,743.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911018014243/0001179110-18-014243-index.htm |
| 2018-12-19 | CAROL SCHAFER | Director | Buy | 5,000.00 | 3.33 | 16,671.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911018014192/0001179110-18-014192-index.htm |
| 2019-01-02 | BROS. ADVISORS LP BAKER | Director | Buy | 3,658.00 | 3.52 | 12,876.16 | 522,563.00 | https://www.sec.gov/Archives/edgar/data/861838/000163859919000063/0001638599-19-000063-index.htm |
| 2019-04-01 | BROS. ADVISORS LP BAKER | Director | Buy | 4,161.00 | 2.59 | 10,776.99 | 526,724.00 | https://www.sec.gov/Archives/edgar/data/861838/000163859919000404/0001638599-19-000404-index.htm |
| 2020-07-13 | Invest Corp Pillar | 10% Share Holder | Buy | 749,993.00 | 1.72 | 1,289,987.96 | 5,427,697.00 | https://www.sec.gov/Archives/edgar/data/861838/000089924320019207/0000899243-20-019207-index.htm |
| 2018-12-24 | MILANO VINCENT | President & CEO | Buy | 15,000.00 | 2.93 | 43,923.00 | 55,816.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911018014244/0001179110-18-014244-index.htm |
| 2020-04-07 | Invest Corp Pillar | 10% Share Holder | Buy | 3,039,514.00 | 1.52 | 4,620,061.28 | 6,260,832.00 | https://www.sec.gov/Archives/edgar/data/861838/000089924320010617/0000899243-20-010617-index.htm |
| 2019-04-01 | HOWARD H PIEN | Director | Buy | 4,392.00 | 2.59 | 11,375.28 | 7,321.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019004543/0001179110-19-004543-index.htm |
| 2020-04-01 | JAMES A GERAGHTY | Director | Buy | 14,926.00 | 1.28 | 19,105.28 | 80,359.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020004660/0001179110-20-004660-index.htm |
| 2019-01-02 | BROS. ADVISORS LP BAKER | Director | Buy | 3,658.00 | 3.52 | 12,876.16 | 85,072.00 | https://www.sec.gov/Archives/edgar/data/861838/000163859919000063/0001638599-19-000063-index.htm |
| 2020-01-07 | MILANO VINCENT | President & CEO | Sell | 3,006.00 | 1.78 | 5,351.88 | 86,560.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020000449/0001179110-20-000449-index.htm |
| 2019-04-01 | BROS. ADVISORS LP BAKER | Director | Buy | 4,161.00 | 2.59 | 10,776.99 | 89,233.00 | https://www.sec.gov/Archives/edgar/data/861838/000163859919000404/0001638599-19-000404-index.htm |
| 2019-01-03 | MILANO VINCENT | President & CEO | Buy | 33,750.00 | 89,566.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911019000526/0001179110-19-000526-index.htm | ||
| 2020-07-01 | JAMES A GERAGHTY | Director | Buy | 10,894.00 | 1.79 | 19,500.26 | 91,253.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020008005/0001179110-20-008005-index.htm |
| 2020-10-01 | JAMES A GERAGHTY | Director | Buy | 8,666.00 | 2.25 | 19,498.50 | 99,919.00 | https://www.sec.gov/Archives/edgar/data/861838/000117911020010220/0001179110-20-010220-index.htm |